Navigation Links
Notre Dame researchers using novel method to combat malaria drug resistance
Date:4/5/2012

Researchers from the University of Notre Dame's Eck Institute for Global Health developed a "gene chip" to contribute to the identification of malaria drug resistance, an effort that will allow for real-time response in modified treatment strategies for this devastating disease.

The new discovery is described in a paper appearing in the latest early online edition of the journal Science. The team of researchers includes Notre Dame's Michael Ferdig, associate professor of biological sciences and doctoral student Becky Miller along with John Tan, managing director of the Genomics Core Facility, in collaboration with Tim Anderson of Texas Biomedical Research Institute and Francois Nosten, M.D., the Shoklo Malaria Unit in Thailand.

"Malaria has tormented humans forever and continues to thwart comprehensive control efforts," Ferdig said. "Resistance eventually emerges to every drug tried and vaccines are always 'on the horizon' but have not yet materialized."

Artemisinin, a natural product from a plant used in China for centuries, is the latest candidate drug to combat multi-drug resistant malaria. However, this last line of defense against malaria world-wide is increasingly falling victim to the problem of malaria drug-resistance. The loss of the drug would be devastating to malaria control efforts.

"For past drugs, most notably chloroquine, discovery of mutations causing resistance and an understanding of how resistance arose and spread has been 'retrospective': too late to do any good, after the drug has already failed," Ferdig said. "We can use our novel method to see resistance as it is emerging, respond in real-time and modify strategies to save a drug, such as protecting it with new formulations and combinations tailored to the specific location of emergence."

The Notre Dame team, working with the project leaders at Texas Biomedical, used the new genomics and bioinformatics approaches to investigate malaria drug-resistance. Tan
'/>"/>

Contact: Michael Ferdig
mferdig@nd.edu
574-631-9973
University of Notre Dame
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Notre Dame researchers describe new tool for evaluating managed relocations
2. Notre Dame study focuses on protein dynamics
3. Twins are intriguing research subjects for Notre Dame biometircs researchers
4. Notre Dame and Wyoming scientists genetically engineer silkworms to produce artificial spider silk
5. Notre Dame researcher helps discover walking properties of bacteria
6. Notre Dame biologists call for regulation of rare plant sales
7. Notre Dame research offers important clues about grasshopper population explosions
8. Breakthrough in Niemann-Pick Type C research reported by Notre Dame and Cornell scientists
9. Notre Dame research reveals brain network connections
10. Notre Dame researchers demonstrate antibiotic sensing event central to MSRA antibiotic resistance
11. Notre Dame researchers report progress on compound to treat neurological diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... or harsh treatments because science fails to identify ... the disease. Researchers at Case Western Reserve University ... that allows patients to safely choose to do ... drastic measures. , The project is one of ... engineering at Case Western Reserve and director of ...
(Date:5/23/2013)... the team reveal the interplay of brain chemicals which ... Wellcome Trust and BBSRC. , By changing the ... perceptual abilities. While these changes can affect the strength ... fidelity of that response. , Lead author ... communicate with others, you can make yourself better heard ...
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3Detecting mirror molecules 2Detecting mirror molecules 3
... discovered how the toxoplasmosis parasite may trigger the development ... from the University of Leeds, Faculty of Biological Sciences ... role in the development of these disorders by affecting ... messages in the brain controlling aspects of movement, cognition ...
... University Life Sciences researchers have discovered a new mechanism ... cells, which could lead to the development of a ... is transmitted to humans through bites from mosquitoes. According ... 350 million and 500 million cases of malaria occur ...
... Strosberg of Scripps Florida, was published on March 4, 2009, ... edition, Papers in Press. In the new study, ... more amino acids) derived from the core protein of hepatitis ... dimerization of the core protein (the joining of two identical ...
Cached Biology News:Research supports toxoplasmosis link to schizophrenia 2Researchers identify new way the malaria parasite and red blood cells interact 2Scripps research team identifies key molecules that inhibit viral production 2Scripps research team identifies key molecules that inhibit viral production 3
(Date:5/24/2013)... Bed bug cases tend to increase during summer. And ... risk of becoming the pests' next victim throughout the season, ... the guide, the company enumerated the steps of getting ... , According to My Cleaning Products, there are two ... during summer: the warm weather and the rise in travel. ...
(Date:5/24/2013)... 2013 The Oklahoma tornado left ... ravage, the mayor of Moore, one of the heavily damaged ... a report from cnn.com. Reaching out to also be of ... and Safe Shield to counter the looming mold problem. , ... May 22, 2013, caused 24 deaths, My Cleaning Products shared. ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... , May 23, 2013 PuraMed BioScience ... and marketer of over-the-counter (OTC) medicinal and healthcare ... opinion on the company based on low market ... , Non-Prescription, All Natural Product to Treat Migraine ... Outperforms #1 Prescription Competitor , Currently Available ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... EDT , EAST BRUNSWICK, N.J., May 6 Savient Pharmaceuticals, ... the three months ended March 31, 2009. For the first ... million, or $0.41 per basic and diluted share, on total revenues ... or $0.33 per basic and diluted share on total revenues of ...
... Therapeutics (Nasdaq: NKTR ) today reported its financial ... loss for the quarter ended March 31, 2009 was $31.8 ... $40.7 million or $0.44 per share in the first quarter ... efficiencies as compared to a year ago. Total operating costs ...
... U.S. President Bill Clinton will,participate as one of the main ... 1 and 3 in Sao Paulo, Brazil. The event is ... of the most,important gatherings focused on biofuels in the world. ... Democratic president awarded a second term,in six decades. After leaving ...
Cached Biology Technology:Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 2Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 3Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 4Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 5Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 6Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 7Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 8Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 9Nektar Therapeutics Reports First Quarter 2009 Financial Results 2Nektar Therapeutics Reports First Quarter 2009 Financial Results 3Nektar Therapeutics Reports First Quarter 2009 Financial Results 4Nektar Therapeutics Reports First Quarter 2009 Financial Results 5Nektar Therapeutics Reports First Quarter 2009 Financial Results 6Nektar Therapeutics Reports First Quarter 2009 Financial Results 7Nektar Therapeutics Reports First Quarter 2009 Financial Results 8Nektar Therapeutics Reports First Quarter 2009 Financial Results 9President Bill Clinton to Speak at the Ethanol Summit in Brazil 2
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... culture supernates and serum. Each kit contains ... fifteen 96-well plates, provided that the following ...
HIV-1 TAT (vN-21)...
Presenilin-1, N-terminus....
Biology Products: